Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BYRisk Management and Healthcare Policy

Quantitative Evaluation of Semaglutide-Associated Changes in Gastric Antral Motility Using Oral Contrast-Enhanced Gastric Ultrasonography

5 affiliations
  1. 1Department of Ultrasound Medicine
  2. 2Department of Medical Imaging
  3. 3Department of Gastroenterology
  4. 4Department of Endocrinology
  5. 5Ultrasound Department

Abstract

Li-Yun Xu,1,&ast; Dong Han,2,&ast; Yuan-Min Zhu,3 Song Dong,4 Lin Li,3 Cui-Xia Liu,1 Jun Guo5 1Department of Ultrasound Medicine, Beijing Changping Hospital of Traditional Chinese Medicine, Beijing, 102200, People’s Republic of China; 2Department of Medical Imaging, Beijing Changping Hospital of Traditionnal Chinese Medicine, Beijing, 102200, People’s Republic of China; 3Department of Gastroenterology, Aerospace Center Hospital, Beijing, 100000, People’s Republic of China; 4Department of Endocrinology, Aerospace Center Hospital, Beijing, 100049, People’s Republic of China; 5Ultrasound Department, Aerospace Center Hospital, Beijing, 100000, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Jun Guo, Ultrasound Department, Aerospace Center Hospital, No. 15 Yuquan Road, Haidian Dist, Beijing, 100049, People’s Republic of China, Tel +86 010-59971199, Email [email protected]: To quantitatively evaluate changes in gastric antral motility before and after semaglutide administration using oral contrast-enhanced gastric ultrasonography, providing imaging-based quantitative evidence for assessing the gastrointestinal effects of semaglutide in clinical practice.Methods: This prospective study enrolled 60 patients with obesity or diabetes mellitus who were randomly assigned to the semaglutide or control group. Gastric ultrasonography was performed at baseline, 4 weeks, and 8 weeks. Concurrently, a gastrointestinal transit test was conducted: patients ingested a barium marker capsule when 200 mL of contrast agent remained, with abdominal radiography performed at 2 and 4 hours post-ingestion.Results: No significant between-group differences were observed at baseline. At 4 weeks following semaglutide injection, all gastric motility indices were significantly reduced (p < 0.05), with further significant decreases at 8 weeks (p < 0.05). Gastrointestinal transit tests demonstrated progressively increased retention of barium markers in the stomach, an elevated gastric transit index, and a decreased barium excretion rate in the semaglutide group compared with the control group (all p < 0.05).Conclusion: Oral contrast-enhanced gastric ultrasonography provides a noninvasive, quantitative method for assessing semaglutide-associated delayed gastric emptying and reduced gastric antral motility. These effects intensify with prolonged treatment duration.Keywords: gastric antral motility, gastric ultrasonography, gastrointestinal transit test, oral gastric ultrasound contrast agent, semaglutide, delayed gastric emptying

Related

  1. The added value of contrast-enhanced ultrasonography to BI-RADS in the evaluation of breast lesions presenting with pathological nipple discharge
    Quantitative imaging in medicine and surgeryPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMC
  2. Pigmented purpura dermatosis associated with compounded semaglutide: A case report and literature review of medication-associated pigmented purpuric dermatosis
    Stephanie Y. Zhang, Maleka Najmi, Katherine H. Fiala
    JAAD case reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  3. Cutaneous Adverse Events Associated with Semaglutide, Liraglutide and Tirzepatide: A Systematic Review
    Aditya K. Gupta, Elizabeth M. Teasell, Renata F. Magalhães +2
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Interactive Panometry: Using Proximal Balloon Distension During Functional Lumen Imaging Probe Panometry to Enhance Motility Evaluation of Inhibitory Function
    Ofer Z. Fass, Muhammed M. Alikhan, John E. Pandolfino +5
    Journal of Neurogastroenterology and MotilityPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
  5. Hemodynamic Compromise Due to Semaglutide-Associated Abdominal Distension
    Matthew B. Amdahl, Vishwesh Bharadiya, Brian Obritsch +7
    JACC Case ReportsPeer-reviewedCC BY-NC-ND 4.0Full text1 citedEndocrinology & metabolismPMC
BibTeX
@article{xu2026quantitative,
  title = {{Quantitative Evaluation of Semaglutide-Associated Changes in Gastric Antral Motility Using Oral Contrast-Enhanced Gastric Ultrasonography}},
  author = {Xu LY and Han D and Zhu YM and Dong S and Li L and Liu CX and Guo J},
  journal = {Risk Management and Healthcare Policy},
  year = {2026},
  month = nov,
  url = {https://www.dovepress.com/quantitative-evaluation-of-semaglutide-associated-changes-in-gastric-a-peer-reviewed-fulltext-article-RMHP},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Quantitative Evaluation of Semaglutide-Associated Changes in Gastric Antral Motility Using Oral Contrast-Enhanced Gastric Ultrasonography
AU  - Xu LY
AU  - Han D
AU  - Zhu YM
AU  - Dong S
AU  - Li L
AU  - Liu CX
AU  - Guo J
PY  - 2026
DA  - 2026/11/15
JO  - Risk Management and Healthcare Policy
UR  - https://www.dovepress.com/quantitative-evaluation-of-semaglutide-associated-changes-in-gastric-a-peer-reviewed-fulltext-article-RMHP
AB  - Li-Yun Xu,1,&ast; Dong Han,2,&ast; Yuan-Min Zhu,3 Song Dong,4 Lin Li,3 Cui-Xia Liu,1 Jun Guo5 1Department of Ultrasound Medicine, Beijing Changping Hospital of Traditional Chinese Medicine, Beijing, 102200, People’s Republic of China; 2Department of Medical Imaging, Beijing Changping Hospital of Traditionnal Chinese Medicine, Beijing, 102200, People’s Republic of China; 3Department of Gastroenterology, Aerospace Center Hospital, Beijing, 100000, People’s Republic of China; 4Department of Endocrinology, Aerospace Center Hospital, Beijing, 100049, People’s Republic of China; 5Ultrasound Department, Aerospace Center Hospital, Beijing, 100000, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Jun Guo, Ultrasound Department, Aerospace Center Hospital, No. 15 Yuquan Road, Haidian Dist, Beijing, 100049, People’s Republic of China, Tel +86 010-59971199, Email [email protected]: To quantitatively evaluate changes in gastric antral motility before and after semaglutide administration using oral contrast-enhanced gastric ultrasonography, providing imaging-based quantitative evidence for assessing the gastrointestinal effects of semaglutide in clinical practice.Methods: This prospective study enrolled 60 patients with obesity or diabetes mellitus who were randomly assigned to the semaglutide or control group. Gastric ultrasonography was performed at baseline, 4 weeks, and 8 weeks. Concurrently, a gastrointestinal transit test was conducted: patients ingested a barium marker capsule when 200 mL of contrast agent remained, with abdominal radiography performed at 2 and 4 hours post-ingestion.Results: No significant between-group differences were observed at baseline. At 4 weeks following semaglutide injection, all gastric motility indices were significantly reduced (p < 0.05), with further significant decreases at 8 weeks (p < 0.05). Gastrointestinal transit tests demonstrated progressively increased retention of barium markers in the stomach, an elevated gastric transit index, and a decreased barium excretion rate in the semaglutide group compared with the control group (all p < 0.05).Conclusion: Oral contrast-enhanced gastric ultrasonography provides a noninvasive, quantitative method for assessing semaglutide-associated delayed gastric emptying and reduced gastric antral motility. These effects intensify with prolonged treatment duration.Keywords: gastric antral motility, gastric ultrasonography, gastrointestinal transit test, oral gastric ultrasound contrast agent, semaglutide, delayed gastric emptying
SN  - 1179-1594
ER  -